Stephen Langabeer

45PUBLICATIONS
3CO-AUTHORS
Haematological tumoursMolecular targetsMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Nov 24, 2023
Molecular diagnostic criteria of myeloproliferative neoplasms.

Claire Andrews, Eibhlin Conneally, Stephen E Langabeer

|May 01, 2023
Imatinib Resistance in Chronic Myeloid Leukemia Associated with a D363G BCR::ABL1 Kinase Domain Mutation.

Stephen E Langabeer, Stuart Macleod, Úna Bhreathnach

|Jan 26, 2023
Pyoderma gangrenosum and myeloproliferative neoplasms.

Stephen E Langabeer

|Jul 09, 2020
Prefibrotic Myelofibrosis Presenting with Multiple Cerebral Embolic Infarcts and the Rare MPL W515S Mutation.

Stephen E Langabeer, Lisa Lee Tokar, Laura Kearney

|Apr 11, 2020
Patient-Initiated Discontinuation of Tyrosine Kinase Inhibitor for Chronic Myeloid Leukemia.

Stephen E Langabeer, Rehman Faryal, Michael O'Dwyer

Pageof 8